Navigation Links
Armune BioScience to Participate in MultiPlan’s Networks, Expanding Access to APIFINY
Date:4/5/2016

Armune BioScience, an emerging leader in cancer diagnostics, has recently completed a national Ancillary Service Agreement with MultiPlan, Inc.

Under the new Agreement, APIFINY® will participate in the PHCS Network, MultiPlan’s national primary network, the MultiPlan Network, MultiPlan’s national complementary network, and ValuePoint by MultiPlan®, a national discount card network used by individuals responsible for paying their own healthcare bills. MultiPlan is the nation’s oldest and largest supplier of independent, network based cost management solutions, with an estimated 68 million consumers accessing its networks.

Launched in the United States in April of 2015, APIFINY is the only cancer specific, non-PSA blood test available to aid clinicians in the risk assessment for the presence of prostate cancer. APIFINY order volume exceeded 5,000 tests in its first year on the market. Primary care physicians and urologists have utilized APIFINY to help move beyond PSA based testing to assess prostate cancer risk.

“We look forward to working with MultiPlan and making APIFINY available to their clients’ healthcare members. Securing a contract with MultiPlan is another example of the potential game-changing clinical and economic value that APIFINY offers,” said David A. Esposito, President and CEO of Armune BioScience. “Given the current concerns of PSA testing throughout the world, APIFINY is well positioned to offer clinicians additional information in the assessment of prostate cancer risk. In addition, we are confident that APIFINY will help to address our healthcare system’s demand for improved outcomes at lower costs.”

APIFINY was developed based on innovative research into the immune system’s response to cancer conducted at the University of Michigan. Armune is currently expanding testing throughout the United States and preparing to launch APIFINY in several markets worldwide. Armune recently retained Mavericks Capital as the company’s advisor and investment bank.

About MultiPlan ( http://www.multiplan.com)
MultiPlan, Inc. is the industry’s most comprehensive provider of healthcare cost management solutions. The company provides a single gateway to a host of network- and analytics-based solutions for managing the financial risks associated with healthcare claims as well as products that fight waste, abuse and fraud before payments are made. Clients include insurers, health plans, third party administrators, self-funded employers, HMOs and other entities that pay medical bills in the commercial healthcare, government, workers compensation and auto medical markets. MultiPlan is owned by an investment group led by Starr Investment Holdings and Partners Group.

About Mavericks Capital ( http://www.maverickscap.com)
Mavericks Capital LLC and its licensed broker dealer, Mavericks Capital Securities LLC, specializes in advising companies on M&A, capital raises and strategic partnerships across the healthcare sector. With a senior team having deep medical perspectives, core scientific knowledge and proprietary analytics, we help construct and facilitate innovative and lucrative solutions for our clients. Our practice areas include therapeutics, devices, diagnostics, services and digital health.

About Armune BioScience ( http://www.armune.com)
Armune BioScience, Inc. is a medical diagnostics company that develops and commercializes unique proprietary technology exclusively licensed from the University of Michigan for diagnostic and prognostic tests for prostate, lung and breast cancers. Armune was incorporated as a Delaware Corporation in 2008 with corporate headquarters in Kalamazoo, MI and a research and commercial laboratory in Ann Arbor, MI.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13311606.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Armune BioScience Expands Access to Apifiny with ARCpoint Labs
2. Armune BioScience Secures Contract for Apifiny with America's Choice Provider Network to Expand Access to Apifiny
3. Armune BioScience Expands Access to Apifiny in Key International Markets with Vantari International
4. Armune BioScience Expands Access to Apifiny with Accu Reference Medical Lab
5. Armune BioScience Announces Agreement Retaining Mavericks Capital as Advisor and Investment Bank
6. Armune BioScience, Inc. Announces the Appointment of Robert W. Reinhardt, MD as Chief Medical Officer
7. Armune BioScience, Inc. Announces Study Results Demonstrating Added Convenience of Apifiny
8. GD Biosciences Announces Availability of the PULs Cardiac Test in India as Part of International Expansion
9. Wayne State opens new $93 million biosciences center aimed at eliminating health disparities in Detroit
10. Sharp Edge Labs and Creagen Biosciences Enter Drug Discovery Collaboration
11. 21st Century Oncology Partners with University of Arizona’s Center for Applied Nanobioscience and Medicine in Phoenix to Advance Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: